US Stocks
/
Quince Therapeutics, Inc. Share Price

Quince Therapeutics, Inc. Share Price

NASDAQ: QNCX | Small Cap
$29.48
+$1.83 (6.62%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Quince Therapeutics, Inc. Stock Performance

Open
$27.32
Prev. Close
$27.65
Circuit Range
N/A
Day Range
$27.32 - $29.29
Year Range
$0.08 - $35.41
Volume
2,899
Average Traded
$28.51

Quince Therapeutics, Inc. Share Price Today

As of 9 October 2026, Quince Therapeutics, Inc.'s share price is $29.48. The stock opened at $27.32, compared to its previous close of $27.65. During today's trading session, Quince Therapeutics, Inc.'s share price traded between $27.32 and $29.29, with an average price of $28.30. Over the past 52 weeks, the stock has recorded a high of $35.41 and a low of $0.08. In terms of performance, Quince Therapeutics, Inc.'s share price has risen by 2185.27% over the last six months and is up 1665.27% on a year-on-year basis.

Quince Therapeutics, Inc. Share Price Chart

$27.32$29.29
L
Show Current Price
H

Quince Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.48B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-93.99
Revenue (TTM)
$0.00
Return On Equity (TTM)
-88.12%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-461.68%

Quince Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.44-$39.46$32.79-$75.49
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-193.60%183.10%-330.22%

Quince Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$51.66-$31.39-$56.83-$83.98
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A39.24%-81.04%-47.77%

About Quince Therapeutics, Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Quince Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$29.95
$29.29
-8.45%
Sep 2026
$33.11
$32.00
-2.63%
Aug 2026
$24.80
$32.86
+38.83%
Jul 2026
$16.77
$23.67
+35.37%
Jun 2026
$1.13
$17.48
+1,413.85%
May 2026
$1.30
$1.16
-10.47%
Apr 2026
$0.10
$1.29
+1,216.33%
Mar 2026
$0.11
$0.10
-19.01%
Feb 2026
$0.16
$0.12
-28.82%
Jan 2026
$3.27
$0.17
-94.92%
Dec 2025
$3.55
$3.35
-8.61%
Nov 2025
$1.59
$3.66
+119.16%

QNCX Share Price FAQs

What is Quince Therapeutics, Inc. share price today?

chevron-up
Quince Therapeutics, Inc. share price today is $29.48 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Quince Therapeutics, Inc. stock?

chevron-up
The 52 week high of Quince Therapeutics, Inc. stock is $35.41, while the 52 week low is $0.08 as of 9 Oct '26.

What is QNCX's market capitalisation today?

chevron-up
QNCX market capitalisation is $1.48B as of October 9, 2026, at 6:11 pm IST.

What is QNCX's net income for the last quarter?

chevron-up
QNCX's net income for the last quarter is -75.49B USD.

What is the 5 year returns of QNCX?

chevron-up
The 5 year returns of QNCX is 123.33% as on 9 Oct '26.

What is the high & low stock price of QNCX today?

chevron-up
QNCX stock price hit a high of $29.29 and low of $27.32 as of 9 Oct '26.

Can I buy QNCX shares in India?

chevron-up
Yes. You can buy QNCX in India by opening an international trading account.